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Insulin is a potent survival factor in mesangial cells: Role of Apoptosis is a physiological and active process whereby
the PI3-kinase/Akt pathway. cells die by suicide. Apoptosis is identified by its character-
Background. Elucidating the mechanisms of apoptosis is im- istic morphological changes, including cellular and nuclearportant for understanding the molecular mechanisms under-
shrinkage, nuclear condensation, membrane blebbing andlying glomerular disease. The phosphatidylinositol 3 kinase
(PI3-kinase)/Akt pathway is essential for survival signaling in cell and nuclear fragmentation [1, 2]. In glomerular dis-
non-renal cells. However, little is known about the anti-apo- ease, cell number is determined by the balance between
ptotic effect of insulin and the role of the PI3-kinase/Akt path- new cell formation by proliferation and cell death by apo-way in mesangial cells (MC) apoptosis.
ptosis [1]. However, apoptosis of glomerular cells can beMethods. Apoptosis was induced in wild type, p27Kip1 (p27)
regarded as a “double-edged sword,” because on one hand/ and p21Cip1/Waf1 (p21) / mouse MC by survival factor
withdrawal, actinomycin D, ultraviolet (UV)-B irradiation and promoting the beneficial deletion of excess resident glo-
cycloheximide in the presence or absence of insulin (1 mol/L) merular cells leads to the resolution of glomerular injury,
or insulin-like growth factor-I (IGF-I; 100 ng/mL). The activa-
whereas excessive apoptosis resulting in hypocellularitytion and levels of Akt, extracellular signal regulated kinase
leads to progressive end-stage kidney failure [1]. Thus,(ERK) and specific cell cycle proteins were determined by
Western blot analysis. elucidating of the mechanisms of apoptosis and its modu-
Results. Insulin and IGF-I inhibited wild-type MC apoptosis lation are important in understanding the molecular mech-
induced by survival factor withdrawal, actinomycin D, ultravio- anisms underlying glomerular disease. Moreover, limit-let-B irradiation and cycloheximide and in p27 / MC when
ing excessive apoptosis may be an important therapeuticapoptosis was induced by survival factor withdrawal. Akt was
activated by insulin and IGF-I during apoptosis. Blocking PI3- strategy to prevent glomerular scarring.
kinase with LY294002 reduced Akt activation and abrogated Insulin is an essential polypeptide that regulates carbo-
the anti-apoptotic effect of insulin. ERK was activated during hydrate, fat and protein metabolism. Studies have shown
apoptosis and blocking ERK activation with U0126 or PD98059
that insulin increases mesangial cell (MC) proliferationpartially rescued MC from apoptosis. Moreover, insulin also
and specific extracellular matrix synthesis [3–5]. Recently,suppressed ERK activation during apoptosis. Our results also
showed that the CDK-inhibitor p21 was increased by insulin other biological functions of insulin have also been shown
and that p21 up-regulation was PI3-kinase/Akt pathway depen- including its pro-survival properties [6, 7]. Activation of the
dent. Furthermore, p21/MC apoptosis induced by survival
insulin receptor tyrosine kinase results in phosphatidyl-factor withdrawal was not rescued by insulin in contrast to the
inositol 3-kinase (PI3-kinase) activation through phospho-wild-type and p27 / MC. These data suggest that p21 may
have a critical role in the anti-apoptotic effect of insulin. rylation of insulin receptor substrate proteins. Activated
Conclusions. Insulin is a potent survival factor for MC in PI3-kinase produces phosphatidylinositol-3,4,5-trisphos-
response to a number of different apoptotic triggers, and this phate (PIP3) and phosphatidylinositol-3,4-bisphosphateeffect is mediated through the PI3-kinase/Akt pathway. More-
[PI(3,4)P2] [6, 7]. These phosphoinositides bind to theover, ERK and p21 may be involved in anti-apoptotic effect
pleckstrin homology domain of Akt and recruit Akt toof insulin in MC.
the plasma membrane. Akt is activated by phosphoryla-
tion at Thr308 by PDK1 and at Ser473 by PDK2 at the
Key words: apoptosis, insulin, mesangial cells, cyclin dependent kinase,
plasma membrane. Activated Akt then phosphorylatesAkt, PI3-kinase/Akt pathway, extracellular signal regulated kinase,
hypocellularity. a series of molecules to suppress apoptosis [6, 8].
Insulin-like growth factor I (IGF-I) is a single chain
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tective effect of IGF-I on apoptosis has been reported performed: (a) the PI3-kinase/Akt signaling pathway was
inhibited by adding 50 mol/L LY294002 (Sigma) to thein several cell types [10–13].
media; (b) the mitogen-activated protein (MAP) kinaseThe mechanisms whereby insulin and IGF-I protect
signaling pathway was inhibited with the MAP kinaseMC from apoptosis are not fully elucidated. Our results
kinase (MEK) inhibitors, U0126 (10 mol/L; Sigma) orshow that the regulation of apoptosis by insulin and
PD98059 (50 mol/L; Calbiochem, San Diego, CA, USA).IGF-I is mediated through the PI3-kinase/Akt pathway.
All experiments were performed a minimum of threeWe also show that insulin increases the expression of
times, and the results represent the mean of these studies.the cyclin dependent kinase (CDK) inhibitor p21Cip1/Waf1
(p21), and also reduces extracellular signal regulated
Measuring apoptosiskinase (ERK) activation during apoptosis.
Apoptosis was examined by Hoechst 33342 staining
(Molecular Probes, Eugene, OR, USA) and careful mor-
METHODS phological analysis as previously reported [16]. Total
Cell culture cell number and the percentage of apoptotic cells were
quantitated in adherent and non-adherent cells usingMesangial cells were isolated from p27Kip1 (p27) wild
an inverted fluorescent microscopy [13]. Six randomlytype (/), p27 null (/) [14] and p21 null (/) [15]
selected fields in each well or dish were counted in tripli-mice by standard glomerular sieving method as we have
cate in each experiment. Apoptosis was reported as adescribed previously [16], and passaged in growth me-
percentage of total cell number.dium of Dulbecco’s modified Eagle’s medium (DMEM;
Irvine Scientific, Santa Ana, CA, USA), 20% (vol/vol) Western blot analysis
Ham’s-F12 (Irvine Scientific), 20% (vol/vol) fetal calf
The activation of Akt, glycogen synthase kinaes-3serum (FCS; Summit Biotechnology, Ft Collins, CO,
(GSK-3) and ERK 1/2 was determined by Western blotUSA), 2 mmol/L glutamine (Sigma, St. Louis, MO,
analysis using a phosphorylation-specific antibody (CellUSA), 10 mmol/L HEPES (Sigma), 100 U/mL penicillin–
Signaling Technology, Beverly, MA, USA). Controls for100 g/mL streptomycin (Irvine Scientific) and 1 trace
the amount of protein loaded was determined by measur-element (Biofluids, Rockville, MD, USA) at 37C in
ing absolute protein levels of Akt, GSK-3 and ERK 1/2.humidified 5% CO2 in air. Insulin was not added to the The protein levels for specific cell cycle proteins also
media during the isolation and culture of MC, except
were measured by western blot analysis as we have pre-
during the experiments described below. viously reported [16].
To extract total protein from cell lysates, cells wereInducing apoptosis
washed with HBSS and trypsinized. After adding ice cold
Mesangial cells (passages 10 to 20) were plated in PBS, cells were centrifuged for five minutes at 500  g,
growth media and cultured until 60 to 80% confluent. washed with ice cold PBS and suspended in a lysis buffer
To induce quiescence, growing cells were washed three containing 1% triton, 10% glycerol, 20 mmol/L HEPES,
times with Hank’s balanced salt solution (HBSS; without 100 mmol/L NaCl (Sigma) with proteinase inhibitor
calcium and magnesium salts; Irvine Scientific) and then cocktail “Complete” (Boehringer Mannheim, Indianap-
incubated for 48 hours in serum-free media (growth me- olis, IN, USA) as previously reported [16]. After a freeze
dia without FCS) for wild-type mouse MC. Apoptosis and thaw procedure, lysates were cleared by centrifu-
was induced using the following experimental design: (a) gation for ten minutes at 17,000  g. Protein concentra-
withdrawal of survival factors by growing cells in serum tion was determined by the BCA protein assay (Pierce,
free media; (b) ultraviolet (UV)-B irradiation; MC were Rockford, IL, USA) according to the manufacturer’s
exposed to (UV-B 302 nm) using a UV transilluminator directions.
source (LM-20e; VWR Scientific, Seattle, WA, USA) for For Western blot analysis, 10 to 40 g protein extracts
10 minutes as described by Martin and Cotter [17], and were separated under reduced conditions on a 12% or
then cultured in serum-free media; (c) actinomycin D; 8% sodium dodecyl sulfate (SDS)-polyacrylamide gel
0.5 g/mL actinomycin D (Sigma) was added to the and transferred to a polyvinylidene difluoride (PVDF)
serum free media; (d) cycloheximide; 100 mol/L cyclo- membrane (Immobilon-P; Millipore, Bedford, MA, USA).
heximide (Sigma) was added to the serum free media. The membranes were incubated with antibodies to:
To determine the effects of insulin and IGF-I on apo- phosphorylation specific Akt (Ser473; Cell Signaling Tech-
ptosis induced by the methods described above, 1mol/L nology), total Akt (Cell Signaling Technology), phos-
insulin (Sigma) or 100 ng/mL recombinant human insulin phorylation specific GSK-3 (Ser9; Cell Signaling Tech-
like growth factor I (IGF-I; Becton Dickson, Bedford, nology), total GSK-3 (BD Transduction Laboratories,
MA, USA) was added to the media. Controls for these Franklin Lakes, NJ, USA), ERK 1/2 (Thr202/Tyr204;
experiments included omitting insulin or IGF-I from the Cell Signaling Technology), total ERK (BD Transduc-
tion Laboratories) and p21 (BD Pharmingen, San Diego,media. The following additional experiments also were
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Fig. 2. Insulin reduced p27 / MC apoptosis. (A) Apoptosis was
induced in proliferating p27/ MC by survival factor withdrawal.
Apoptosis was reduced by 1 mol/L insulin in p27 / MC at 24 hours
compared to control cells without insulin. (B) Apoptosis induced by
the withdrawal of survival factors alone was reduced by insulin in
p27 / MC at 24 hours in a dose-dependent manner.
Fig. 1. Insulin reduces apoptosis in wild-type mesangial cells (MC).
(A) Apoptosis was induced in proliferating wild-type MC by several
apoptotic triggers, and then exposed to insulin () or control (no insulin,
induced by survival factor withdrawal, UV-B irradiation,). Apoptosis was examined 12 hours after the induction of apoptosis.
Insulin reduced apoptosis induced by survival factor withdrawal alone cycloheximide and actinomycin D. As shown in Figure
(SF), ultraviolet-B irradiation (UV-B), cycloheximide (CHX), and acti- 1A, insulin significantly inhibited apoptosis induced bynomycin D (Act D). (B) The reduction in wild-type MC apoptosis by
insulin was dose-dependent, and was maximum at a concentration of these four forms of injury. The inhibition of cyclohexi-
1 mol/L. mide-induced apoptosis by insulin suggests that the pro-
tective effect of insulin occurs in the absence of new
CA, USA). Primary antibodies were incubated overnight protein synthesis. The effect of insulin was dose depen-
at 4C, followed by incubation with an alkaline phospha- dent, being maximal at 1.0 mol/L concentration (Fig.
tase-conjugated secondary antibody (Promega, Madison, 1B). We also studied the effect of insulin on apoptosis
WI, USA) at room temperature for 60 minutes. Protein
in quiescent MC. Insulin significantly suppressed apopto-detection was determined using chromagen 5-bromo-4-
sis in quiescent MC induced by actinomycin D and UV-Bchloro-3-indolyl phosphate/nitro blue tetrazolium (Sigma).
(data not shown).
Statistical analysis We have previously reported that p27 / MC are
Results in this study were expressed as mean  SEM. more susceptible to apoptosis compared to control p27
Statistical analysis was evaluated by the Student t test, / MC [16], and that p27 also protects renal cells from
using the StatView 5.0.1 software program (Abacus Con- apoptosis in vivo [14]. To determine if insulin could over-
cepts, Berkeley, CA, USA). come the absence of the CDK-inhibitor p27, asynchro-
nized proliferating p27 / MC were deprived of sur-
RESULTS vival factors (serum starved) for 24 hours in the presence
Insulin reduces MC apoptosis of different concentrations of insulin. As shown in Fig-
ure 2, insulin significantly protected p27 / MC fromFirst the anti-apoptotic effect of insulin was investi-
gated on proliferating wild-type (/) MC apoptosis apoptosis, and this effect was dose dependent.
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Fig. 3. Akt is phosphorylated at Ser473 by
insulin, as shown by Western blot analysis.
(A) Apoptosis was induced in quiescent wild-
type MC by actinomycin D (Act D). Akt was
unphosphorylated in viable wild-type MC
(0 h) not exposed to Act D. Act D did not
alter Akt phosphorylation (Phospho-Akt), in
the absence of insulin (-). In contrast, Akt
was phosphorylated by insulin () in Act D
injured MC. (B) Apoptosis was induced in
proliferating p27/MC by serum starvation
in the presence () or absence () of insulin.
Akt was unphosphorylated in p27 / MC
following the withdrawal of survival factors
(cells grown in serum free media). The de-
crease in apoptosis in p27 / MC following
exposure to insulin () was associated with
phosphorylation of Akt at Ser473 (Phospho-
Akt). The amount of total Akt was not
changed in either experiment, confirming that
protein loading was equal.
Akt is activated by insulin
We next determined if an anti-apoptotic effect of insu-
lin is mediated by Akt activation. Because Akt is acti-
vated by phosphorylation at Ser473, the phosphorylation
status of Akt was examined by Western blot, using a
phosphorylation-specific Akt antibody. As shown in Fig-
ure 3A, Akt is unphosphorylated in quiescent wild-type
MC. Akt remained unphosphorylated following actino-
Fig. 4. Insulin phosphorylates glycogen synthase kinase-3 (GSK-3)mycin D induced apoptosis. In contrast, Akt was phos-
as shown by Western blot analysis. Apoptosis was induced in proliferat-
phorylated by insulin treatment following actinomycin ing p27 / MC by survival factor withdrawal. GSK-3 was unphos-
phorylated in the absence of insulin (). The protective effect of insulinD-induced apoptosis. Taken together, these results show
() on apoptosis was associated with phosphorylation of GSK-3 atthat Akt phosphorylation was associated with anti-apo- Ser9 (Phospho-GSK-3). Total GSK-3 protein was unaltered, indica-
ptosis. tive of equal protein loading.
The effect of insulin on Akt phosphorylation was also
studied in p27/MC. In proliferating p27/MC, Akt
by Akt phosphorylation and activation, we examined thewas phosphorylated prior to survival factor withdrawal
phosphorylation of GSK-3 using a phosphorylation-(Fig. 3B). In contrast, Akt was dephosphorylated follow-
specific GSK-3 antibody, because GSK-3 phosphory-ing the withdrawal of survival factors (serum starved) in
lation is required in the PI3-kinase/Akt survival pathwaythe absence of insulin, and this coincided with the onset
[18, 19]. As shown in Figure 4, GSK-3 was markedlyof apoptosis. However, despite survival factor withdrawal,
phosphorylated by insulin, an event that occurred within
adding insulin to the medium, which rescued cells from one hour. GSK-3 phosphorylation by insulin was sus-
apoptosis, was associated with the phosphorylation of tained to 12 hours.
Akt. These results show that the phosphorylated form
Anti-apoptotic effect of insulin is PI3-kinase/Aktof Akt is associated with cell viability, and that the anti-
pathway dependentapoptotic effect of insulin is associated with Akt phos-
phorylation. To determine if the protective effect and survival prop-
erties of insulin mediated by Akt was PI3-kinase depen-To determine which specific proteins were regulated
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Fig. 6. Akt phosphorylation by insulin is PI3-kinase dependent as
shown by Western blot analysis. Akt was unphosphorylated in quiescent
wild-type MC (A) and in serum-starved proliferating p27 / MC (B)
in the absence of insulin (lane 1). Akt was phosphorylated (Phospho-
Akt) by insulin at 15 minutes (lane 2). Phosphorylation of Akt by
insulin was prevented when PI3-kinase was inhibited by LY294002
(lane 3). Total Akt, the control for protein loading, was similar in
experimental and control cells.
Fig. 5. Phosphatidylinositol 3-kinase (PI3-kinase) is required for the
anti-apoptotic effect of insulin. (A) Insulin reduced quiescent wild-type
MC apoptosis induced by actinomycin D at 12 hours in the absence MC is not known. Our results showed that 100 ng/mLof the PI3-kinase inhibitor LY294002 (lane 2). Inhibiting PI3-kinase
IGF-I significantly inhibited apoptosis in both wild typeabrogated the anti-apoptotic effect of insulin (lane 3). LY294002 alone
without insulin enhanced apoptosis (lane 4). (B) Insulin reduced prolif- and p27 / MC to the same extent as that observed
erating p27 / MC apoptosis at 24 hours induced by survival factor
with 1mol/L insulin treatment (data not shown). More-withdrawal in the absence of LY294002 (lane 2). Inhibiting PI3-kinase
with LY294002 reduced the survival effects of insulin (lane 3). LY294002 over, the phosphorylation of Akt by IGF-I was confirmed
alone without insulin enhanced apoptosis (lane 4). by Western blot (data not shown). These results demon-
strate that IGF-I also protects MC apoptosis through
PI3-kinase/Akt pathway and that their effects were
comparable.dent, the PI3-kinase inhibitor LY294002 was added. It
significantly abolished the protective effect of insulin on
ERK is activated during apoptosis and insulin inhibitsapoptosis in both wild type and p27/MC as shown in
ERK activationFigure 5. Moreover, blocking Akt phosphorylation with
To determine the role of MAP kinase signaling duringLY294002 was also confirmed by Western blot analysis
the anti-apoptotic effects of insulin, the phosphorylation(Fig. 6). Taken together, these results show that Akt phos-
status of ERK 1/2 was examined using a phosphoryla-phorylation is PI3-kinase dependent and that insulin re-
tion-specific ERK 1/2 antibody. ERK activation wasquires PI3-kinase activation to protect MC from apoptosis.
studied during actinomycin D-induced apoptosis in the
IGF-I also activates PI3-kinase/Akt pathway presence or absence of insulin. Interestingly, phosphory-
and protects MC from apoptosis lated ERK was increased during apoptosis, and this up-
regulation was suppressed by insulin (Fig. 7A). To deter-Although IGF-I also is a survival factor for MC [13],
the role of the PI3-kinase/Akt pathway on this effect in mine the relationship between PI3-kinase and ERK, wild
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Fig. 7. Insulin reduces ERK 1/2 phosphoryla-
tion as shown by Western blot analysis. (A)
In the absence of insulin (), actinomycin D
induced apoptosis in quiescent wild-type MC
and this was associated with phosphorylation
of ERK 1/2 at Thr202 and Tyr204 (Phospho-
ERK 1/2). Insulin () reduced ERK 1/2 phos-
phorylation, and this was associated with a
marked decrease in apoptosis. (B) Inhibiting
PI3-kinase with LY294002 abrogated the sup-
pressive effect of insulin on ERK phosphory-
lation (Phospho-ERK 1/2; lane 4) at six hours.
Total ERK 1/2, a control for protein loading,
was not changed.
type MC were pretreated with LY294002 and ERK acti- ure 9A, p21 protein levels were increased by insulin in
vation was measured six hours after actinomycin D treat- quiescent cells. Our results also showed that the increase
ment. The suppressive effect of insulin on ERK activa- in p21 was abolished by pretreatment of the PI3-kinase
tion was partially abrogated by LY294002 (Fig. 7B). inhibitor LY294002 (Fig. 9B). Thus, p21 up-regulation
To clarify the significance of ERK activation during is dependent on the PI3-kinase/Akt pathway.
apoptosis, we used the selective MEK inhibitor U0126. We next determined p21 levels following actinomycin
Quiescent wild-type MC were treated with actinomycin D induced apoptosis in wild-type MC. As shown in Fig-
D to induce apoptosis, and U0126 was added one hour ure 10, p21 levels decreased during apoptosis (in the
prior to the administration of actinomycin D, or two hours absence of insulin). In contrast, insulin increased p21
after actinomycin D. Giving U0126 before actinomycin levels following actinomycin D-induced injury, and this
D did not effect apoptosis (Fig. 8A). In contrast, adding correlated with a protective role for insulin.
U0126 after actinomycin D treatment partially inhibited
Insulin does not protect apoptosis in p21/ MCapoptosis (Fig. 8A). To ensure that this effect was not spe-
cific to one MEK inhibitor, the MEK inhibitor PD98059 To clarify the role of CDK-inhibitor p21 in apoptosis,
also was used. Our data showed that PD98059 signifi- MC derived from p21 / mice were used. Figure 11
cantly inhibited the apoptosis induced by actinomycin shows that apoptosis induced by survival factor with-
D treatment (Fig. 8B). These results suggest that ERK drawal was increased in p21/ MC, compared to wild
activation during apoptosis is pro-apoptotic and that the type MC. Interestingly, insulin did not protect p21 /
anti-apoptotic effect of insulin is mediated in part by MC from apoptosis. In contrast, insulin protected the
suppressing ERK activation. cells from apoptosis in wild type and p27/ MC.
The CDK-inhibitor p21 is increased by insulin
DISCUSSIONThe cyclin-dependent kinase inhibitor, p21, has been
The roles of insulin and IGF-I in the progression inshown to have variable effects on apoptosis, and these
proliferation and the synthesis of specific extracellularmay be cell type and injury dependent [20–25]. We first
matrix proteins have been shown in renal disease [3–5,examined the effect of insulin on p21 expression in quies-
cent wild-type MC exposed to insulin. As shown in Fig- 26]. Increased cell number can be due to an increase in
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Fig. 9. Insulin increases p21 expression through PI3-kinase dependent
pathway as shown by Western blot analysis. (A) Insulin increased the
protein levels of CDK-inhibitor p21 when added to quiescent wild type
MC. (B) p21 protein levels were increased by insulin at 12 hours (lane
2), and the increase was prevented when PI3-kinase was inhibited by
LY294002 (lane 3).
insulin protects MC from apoptosis through the suppres-
sion of ERK 1/2 activation.
A characteristic response to MC injury is apoptosis.
This study shows that insulin and IGF-I were potent sur-
vival factors in MC in response to a variety of apoptotic
triggers, including survival factor withdrawal, actinomy-
cin D, UV-B irradiation, and cycloheximide. Although pre-
vious studies have shown that IGF-I protects MC from
apoptosis, the mechanisms underlying the protection
were not clarified. Previous studies have shown that insu-
lin and IGF-I signal through the same pathways. Accord-
ingly, we used both these ligands interchangeably in our
studies. The first major finding in the current study was
that insulin phosphorylated Akt in MC, and that inhib-
iting PI3-kinase reduced Akt phosphorylation. More-
over, inhibiting the PI3-kinase/Akt pathway markedly
reduced the anti-apoptotic effect of insulin on MC. We
have previously shown that the CDK-inhibitor p27 pro-Fig. 8. Inhibiting MAP kinase kinase (MEK) partially inhibits apopto-
tects cells from apoptosis in vitro and in vivo [14, 16], andsis. (A) Incubating quiescent wild-type MC with the MEK inhibitor
U0126 before (Pre) exposing MC to actinomycin D did not alter apopto- therefore were interested to determine how these cells
sis at 12 hours (lane 2). Adding U0126, two hours after exposing MC lacking p27 could be protected from apoptosis. The cur-to actinomycin D, partially reduced apoptosis. (B) Adding the MEK
rent study shows that exposing MC to insulin and IGF-Iinhibitor PD98059, two hours after exposing MC to actinomycin D,
also reduced apoptosis. overcame the pro-apoptotic effect of absent p27 levels
in p27/ MC. Moreover, similar to wild type MC, the
protection of p27/ MC by insulin and IGF-I from
apoptosis was also PI3-kinase/Akt dependent. Taken to-
proliferation, and/or a reduction in apoptosis. The role of gether, these results show that the PI3-kinase/Akt path-
insulin and IGF-I in mesangial cells (MC) from apoptosis way is a critical mediator of insulin’s anti-apoptotic ef-
and the signaling pathways that mediate these effects fect on MC.
are not well established. Our current study shows that An anti-apoptotic role of insulin and IGF-I has re-
the anti-apoptotic effect of insulin on MC is dependent cently been reported in different non-renal cell types
on the PI3-kinase and Akt pathway, and that the CDK- [27–31]. Insulin prevents tumor necrosis factor (TNF)-
induced apoptosis in human umbilical vein endothelialinhibitor p21 is downstream of it. We also show that
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Fig. 10. p21 is up-regulated during actinomycin D apo-
ptosis by insulin treatment as shown by Western blot
analysis. The protein levels of p21 were decreased dur-
ing actinomycin D-induced apoptosis in quiescent wild-
type MC in the absence of insulin (). In contrast, the
decrease in apoptosis was associated with increase of
p21 levels by insulin ().
However, we were unable to detect Ser136 phosphoryla-
tion of BAD (data not shown). This might be due to the
sensitivity of antibody or that BAD phosphorylation at
Ser 136 may not be essential to protective effect of insu-
lin in MC.
Extracellular signal-regulated kinase, a member of the
MAP kinases family, is activated by mitogenic growth
factors and is involved in the regulation of cell prolifera-
tion. However, the role of ERK in apoptosis remains
controversial. Activation of ERK has been reported to
suppress apoptosis in some studies [33, 34], whereas acti-
vated ERK is pro-apoptotic in others [35, 36]. A third
finding in the current study was that ERK is activated dur-
ing apoptosis, and that apoptosis was suppressed when
MEK inhibitors (U0126 and PD98059) were added prior
to ERK activation. These results show that activated
Fig. 11. Apoptosis is increased in p21 / MC and not protected by ERK is pro-apoptotic in MC under the apoptotic condi-insulin. Apoptosis was induced by survival factor withdrawal in wild-
tions used in this study. In contrast, the MEK inhibitortype, p21 / and p27 / MC, and measured at 24 hours. Apoptosis
was increased in p21 / MC compared to control wild-type MC. In U0126 did not reduce MC apoptosis when added one
contrast to wild-type and p27 /MC, insulin did not inhibit apoptosis hour prior to the induction of apoptosis. A dual effect ofin p21 / MC. Symbols are: () no insulin; () insulin.
ERK activation in the control of MC survival has been
reported. Studies have shown that the transient activa-
tion of ERK participates in the induction of apoptosis,
and oxidative stress induced apoptosis in rat cardiomyo- whereas the basal and constitutive activity is required for
cytes [28, 29]. IGF-I promotes the survival of cerebellar the maintenance of cell survival [37]. Different inhibitory
neurons from serum depletion induced apoptosis and effects of MEK inhibitor by the administration timing in
the survival of fibroblast from UV-B induced apoptosis our study may be explained by the dual action of ERK
[10, 11]. on cell survival and apoptosis. We propose that pretreat-
To explore potential downstream proteins that could ment with U0126 inhibited basal levels of ERK, which
be phosphorylated by Akt, we first examined the ubiqui- are required for cell survival, as U0126 is a strong inhibi-
tously expressed protein-serine/threonine kinase GSK-3. tor of ERK activation, so the beneficial effect of sup-
A second finding in this study was that GSK-3 was phos- pressing ERK during apoptosis would be diminished.
phorylated during the protective effect of insulin. GSK-3 Taken together, a major finding in this study is that ERK
activation during apoptosis is suppressed by insulin. Thehas been identified as a physiological target of Akt and its
kinase activity is inhibited by phosphorylation. Previous mechanism requires further study. One could speculate
that “cross talk” between the PI3-kinase/Akt pathway andstudies have shown that the overexpression of catalyti-
cally active GSK-3 induced apoptosis, whereas the domi- MAP kinase pathway may exist to regulate cell survival
and apoptosis. That the inhibiting effect of insulin onnant-negative GSK-3 prevented apoptosis following in-
hibition of PI3-kinase [19]. Taken together, our results ERK activation during apoptosis was abrogated by pre-
treatment with PI3-kinase inhibitor further strengthenssuggest that GSK-3 is also a target downstream protein
of Akt in MC. We next examined BAD, one of the Bcl2- this idea.
The cyclin-dependent kinase inhibitor p21 reducesfamily proteins, to explore the downstream proteins of
Akt. It is reported that the pro-apoptotic gene BAD is cell proliferation by binding to specific cyclin-CDK com-
plexes [38]. The fourth major finding in the current studyphosphorylated at Ser136 by Akt, which is linked to
its anti-apoptotic effect by binding 14-3-3 protein [32]. was that p21 levels were increased by insulin in MC, and
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6. Downward J: Mechanisms and consequences of activation of pro-that the increase was PI3-kinase/Akt dependent. To show
tein kinase B/Akt. Curr Opin Cell Biol 10:262–267, 1998
a functional role for p21 in mediating the anti-apoptotic 7. Alessi DR, Downes CP: The role of PI 3-kinase in insulin action.
effects of insulin, we utilized MC derived from p21 / Biochim Biophys Acta 1436:151–164, 1998
8. Khwaja A: Akt is more than just a Bad kinase. Nature 401:33–mice. p21 / MC showed increased apoptosis com-
34, 1999pared to wild type MC. Moreover, insulin did not rescue 9. Hirschberg R, Adler S: Insulin-like growth factor system and the
apoptosis in p21 / MC (in contrast to wild type MC kidney: Physiology, pathophysiology, and therapeutic implications.
Am J Kidney Dis 31:901–919, 1998and p27 / MC). These data therefore suggest that
10. Kulik G, Klippel A, Weber MJ: Antiapoptotic signalling by thep21 participates in the anti-apoptotic effects of insulin, insulin-like growth factor I receptor, phosphatidylinositol 3-kinase,
and that p21 protects against apoptosis in MC. Several and Akt. Mol Cell Biol 17:1595–1606, 1997
11. Dudek H, Datta SR, Franke TF, et al: Regulation of neuronalreports have demonstrated that p21 protects cells from
survival by the serine-threonine protein kinase Akt. Scienceapoptosis in vitro and in vivo [20–23]. Moreover, p21 275:661–665, 1997
was recently reported to be increased by IGF-I and may 12. Morales MP, Galvez A, Eltit JM, et al: IGF-1 regulates apoptosis
of cardiac myocyte induced by osmotic-stress. Biochem Biophysbe critical for myoblast survival [39]. The mechanism
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